Immunologic monitoring in carcinoma of the breast.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D007167:Immunotherapy; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008934:Mitogens / Q000494:pharmacology; D009364:Neoplasm Recurrence, Local; D012306:Risk; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology
D000970:Antineoplastic Agents; D008934:Mitogens